| Analysis of polyadenylation site usage of the c-myc oncogene. | None |
| Flow cytometric correlation of the c-myc oncoprotein and cell cycle kinetics of HL60 leukaemia during induced maturation with cytosine arabinoside and dimethylsulphoxide. | None |
| Normal expression of a rearranged and mutated c-myc oncogene after transfection into fibroblasts. | None |
| a functional link between Myc, a renowned oncogene, and the essential nucleotide biosynthetic enzyme CTPsyn. | None |
| Enhanced transcription of c-myc proto-oncogene in spleen lymphocytes from lupus-prone mice during the growing process. | None |
| Immunocytochemical study of ras and myc proto-oncogene polypeptide expression in the human menstrual cycle. | None |
| H. pylori induced activation of NF-kappaB and AP-1, cell proliferation, and expression of oncogenes (beta-catenein, c-myc) in AGS cells, which was inhibited by transfection of MAD3 and TAM67. | None |
| tissue-specific downregulation of the Drosophila homolog of human c-myc proto-oncogene (dMyc) suppresses tau-mediated morphological and functional deficits by reducing abnormal tau hyperphosphorylation and restoring the heterochromatin loss. | None |
| Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes has been analyzed in a multi-cancer bioinformatics approach. | None |
| Study identified a novel epigenetic mechanism showing how JMJD6 cooperates with Myc during oncogenic transformation. Combined high expression of Myc and JMJD6 confers a more aggressive phenotype in mouse and human tumors. | None |
| These results indicate that miR-25 has anti-apoptosis roles in AGS cells, possibly via inhibiting FBXW7 and thus promoting oncogenes, such as CCNE1 and MYC. | None |
| N-myc gene expression and oncoprotein characterisation in medulloblastoma. | None |
| Amplification of N-myc oncogene in various childhood cancers. | None |
| TGF-beta1 increased OSCC cell proliferation by upregulating the expression of DeltaNp63 and c-Myc oncogenes. Although the basal OSCC cell proliferation is sustained by activating DeltaNp63, increased induction of c-Myc causes unregulated OSCC cell proliferation. | None |
| Studies indicate that eukaryotic translation initiation factor 6 (eIF6) is a central regulator of metabolism independent from mTOR protein and myc proto-oncogene protein (Myc). | None |
| Establishment of a human malignant meningioma cell line with amplified c-myc oncogene. | None |
| any of the molecules or processes in the network could be targeted to curb the oncogenic effects of c-Myc, just as BRD4 can be targeted. And since the targeting of metabolic enzymes has proved effective in mouse tumor models, it might be possible to develop new therapies based on the fact that c-Myc has a role in controlling cellular metabolism | None |
| In vivo and in vitro stimulation by antitumor drugs of the topoisomerase II-induced cleavage sites in c-myc proto-oncogene. | None |
| The role of the oncogene c-myc in sporadic large bowel cancer and familial polyposis coli. | None |
| BRG1/BRM and c-MYC have an antagonistic relationship regulating the expression of cardiac conduction genes that maintain contractility, which is reminiscent of their antagonistic roles as a tumor suppressor and oncogene in cancer. | None |